Electronic Prescribing of Controlled Substances (EPCS) can help tackle one of the most serious epidemics in the US today: prescription drug abuse. Twice as many deaths result from prescription drug overdose than from cocaine and heroin overdoses combined. In 2010, with almost 50 percent of all substance abuse deaths related to prescription drug overdose, the DEA responded by finalizing a rule allowing electronic prescribing of controlled substances (EPCS).
Imprivata Confirm ID, the First Comprehensive Product that Simplifies Adoption of Regulatory Requirements for EPCS, Helps Providers Address Inefficiencies and Potential Fraud Caused by Paper-Based Prescriptions
Fred Gebhart
February 10, 2015
Pharmacists across New York are processing some of their last paper prescriptions. As of March 27, all Rxs filled by New York pharmacists must be electronic, including those for controlled substances. With a few minor exceptions, paper is about to become history in one of the largest Rx markets in the country.
Alex Perala
February 9, 2015
Imprivata, an IT security company focused on healthcare, has announced the launch of a new electronic medical prescription platform. Imprivata Confirm ID is now available for medical professionals to prescribe controlled substances digitally, allowing for greater efficiency and reliability of documentation and records-keeping.
Stacey Collett
February 04, 2015
Each year, the CSO50 awards honor 50 security projects and initiatives that have delivered groundbreaking business value through the innovative application of risk and security concepts and technologies.